Table 5.
The burden of disease in Germany based on prevalence data from the literature
| |
|
|
|
Sickness fund perspective |
Societal perspective |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | Study origin | Prevalence | Lower limit (2.5%) | Burden (mean) | Upper limit (97.5%) | Direct costs | Indirect costs | Lower limit (2.5%) | Burden (mean) | Upper limit (97.5%) | |
| This study |
2007/2008 |
Germany |
4.95 |
€187.6 m |
€201.1 m |
€223.6 m |
€189.7 m |
€132.0 m |
€302.3 m |
€321.7 m |
€341.3 m |
| Orphanet database2 |
2011 |
not stated/global |
3.00 |
€113.8 m |
€122.0 m |
€135.6 m |
€115.0 m |
€80.1 m |
€183.4 m |
€195.1 m |
€207.0 m |
| Reis et al.1 |
2000 |
Germany |
4.53 |
|
|
|
€262.0 m |
€52.0 m |
|
€314.0 m |
|
| Reis et al. (adj.)2 |
2007/2008 |
Germany |
4.53 |
€171.8 m |
€184.3 m |
€204.9 m |
€173.7 m |
€121.0 m |
€277.0 m |
€294.7 m |
€312.7 m |
| SEER database2 | 2008 | USA | 3.47 | €131.6 m | €141.1 m | €156.9 m | €133.1 m | €92.6 m | €212.1 m | €225.7 m | €239.5 m |
1) as reported by Reis et al. (2006); 2) calculated based cost data of this study.